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Summary We studied the spatial relationship within the breast between multicentric foci (MCF) and the
primary tumour in 30 modified radical mastectomy specimens using Egan's correlated pathological
radiological method using 5 mm slices of the whole breast. The relative positions within the breast of the
primary tumour and MCF were used to calculate the relative distribution of primary tumour and MCF in the
four quadrants of the breast and the per cent breast volume that would be required to be excised to include all
MCF. Nineteen (63%) breast harboured MCF. The relative distribution of primary tumour and MCF in the
four breast quadrants was significantly different (P=0.034). MCF were present beyond the index quadrant
(25% of breast volume including the tumour) in as many as 79% (15/19) of breasts that harboured MCF; and
in half the cases (15/30) when all breast were considered. This is in variance with the suggestion put forward
previously that MCF are contained within the index quadrant in 90% of cases. Although the number of
patients in the present series is small, the probability of our finding being due to play of chance is 1 in 1500. In
a large series of breast conservation studies >90% of early breast recurrences have been found to occur in the
index quadrant. Our finding, that in half the patients (15/30) MCF are present in quadrants other than the
index quadrant, suggests that MCF do not give rise to early breast recurrence.
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Many studies have investigated the multicentric nature of
breast cancer (Qualheim, 1957; Gallager, 1969; Hutter, 1971;
Shah et al., 1973; Rosen et al., 1975; Lagios, 1977; Westman-
Naeser et al., 1981; Sarnelli, 1986; Spinelli et al., 1992;
Anastassiades et al., 1993). Although some of these studies
(Gallager, 1969; Hutter, 1971; Lagios, 1977) used radio-
graphy, it was Egan (Egan et al., 1969; Egan, 1982) who
standardised the 'correlated pathological-radiological' meth-
od of whole-organ analysis, which provides optimum
sampling of breast tissue. The incidence of multicentricity
found in these studies varied from 18%, when 1-2 random
samples from each quadrant were examined (Spinelli et al.,
1992), to 69% when 5 mm sections of whole breast were
examined using Egan's method (Egan, 1982). The principle
aim of all these studies was to find the incidence of
multicentric foci (MCF) in the breast. Holland et al. (1985)
in their landmark paper addressed the additional issue of
spatial distribution of MCF in terms of their distances from
the primary tumour. They showed that MCF were within
2 cm of the tumour edge in 53% of patients and within 4 cm
in 90% of patients. The findings expressed in this manner
gave the impression that most MCF are present close to the
tumour.
We studied the spatial relationship within the breast of
multicentric foci (MCF) with respect to the primary tumour
in 30 patients using Egan's technique. We used two new
approaches to this problem: (1) we plotted the relative
distribution of MCF and the primary tumour within the four
breast quadrants; and (2) we calculated the volume of breast
tissue that would be required to be surgically excised,
expressed as a per cent of the total breast volume to include
all MCF.
Method
Thirty modified radical mastectomy specimens were studied.
All patients had their diagnosis established by fine needle
aspiration cytology with the primary tumour in situ. The
patients had opted for modified radical mastectomy after all
available surgical options, including conservative surgery, had
been explained to them. The specimens were studied using
Egan's correlated pathological-radiological method, which
involves freezing, slicing, radiography, grossing and micro-
scopy (Egan et al., 1969; Egan, 1982). The superior and lateral
margins of the breast specimen were marked with ink. Axillary
tissue was excised and processed separately for dissection of
axillary lymph nodes, so that the patient's definitive treatment
was not delayed. The breast specimen was placed in a tray,
covered with silver foil and kept at -80°C for 4-24 h. A
transverse line across the nipple was marked to indicate the
plane of the x-axis (see below). The breast was sliced using a
ham slicer. Slices 5 mm thick were cut in the sagittal plane
starting from the medial side. The slices were laid on acrylic
sheets and were radiographed with mammography machine
(100 mA and 22 kV) using high-quality mammography plates.
The radiologist examined the mammograms and marked any
suspicious areas. Gross examination of the slices was then
carried out. In every slice, areas that looked or felt suspicious to
palpation, and those marked on radiographs, were excised.
These suspicious areas were fixed in formalin, embedded in
paraffin and studied microscopically. The following lesions
were considered as significant: a focus showing ductal
hyperplasia with atypia (ADH), ductal carcinoma in situ
(DCIS), infiltrating duct carcinoma (IDC), atypical lobular
hyperplasia (ALH), lobular carcinoma in situ (LCIS) and
infiltrating lobular carcinoma (ILC). The analysis for spatial
distribution as described below was repeated after exclusion of
ADH, ALH and LCIS.
For orientation in space, we considered the breast to be a
hemisphere. The point on the base of the breast directly
below the nipple was considered the origin of the frame of
reference. The horizontal line from medial to lateral side
across the nipple was called the x-axis; the vertical line from
inferior to superior edge across the nipple was called the y-
axis; and the line from the origin to nipple was called the
axis. All measurements were made in cm. The slice through
the nipple was numbered 0; the medial slices were numbered
-1, -2, -3... and the lateral slices + 1, + 2, + 3... The x,
and z coordinates of the centre of each suspicious MCF were
then measured. As each slice was 0.5 cm thick, the slice
number divided by 2 was equal to the x co-ordinate in cm.
The v and coordinates were measured on each slice. The
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radius of the tumour and all three coordinates of the tumour
centre were also measured. These co-ordinates indicated the
position within the breast of MCF and the primary tumour.
We then calculated (1) distances of MCF from the tumour
edge, (2) the relative distribution of primary tumour and
MCF in the four quadrants of the breast, and (3) per cent
breast volume that would be required to be excised to include
all MCF. The Microsoft Excel version 5.0 computer program
was used for the above calculations. We wish to point out
that the last two methods of analysis are novel and have not
been attempted by previous investigators.
The following calculations were made:
(1) Distance of each MCF from edge of tumour was
calculated using the formula:
df = fxf-xt)2 + (yf _ yt)2 + (zf _ Zt)2 _ rt
df=Distance of each MCF from the edge of the tumour,
xf, yf, zf=the co-ordinates of the MCF
xt, yt, zt=the co-ordinates of tumour centre and
rt=the radius of the tumour
(2) The relative distribution of the MCF and primary
tumour in the four quadrants of the breast were calculated
and plotted in two dimensions using the x and y co-ordinates.
(3) For each case, the total breast volume (Vb) and the
volume of breast tissue that would be required to be excised
so that all MCF are included (Vt) was calculated. We
expressed the latter as per cent of total breast volume. The
following formulae were used for this calculation:
Total volume of breast (Vb) = 2/3 x H x h/2 x b/2 x w,
Breast volume that would be required to be excised to
include the farthest MCF
(Vt) = 4/3 x H x (rt x df) x (ht) x (bt)
The percentage of breast volume that would be required to
be excised to include all MCF = Vt/Vb x 100
(h= vertical height, b= horizontal width and w= depth of
the breast at nipple, ht and bt= the height and breadth ofthe
breast at the site of the tumour or (rt+d/) whichever is
smaller).
Statistical analysis was done using the chi square test and
standard tests for correlation and regression.
Results
The patients' ages ranged from 28 to 72 years (mean 49
years). Twenty patients were post-menopausal and ten were
premenopausal. The mean breast dimensions were: height,
15 cm (range 9.5-18.5 cm); breadth, 13 cm (range 10-
17 cm); and depth, 4.5 cm (range 3-5.5 cm). Mean tumour
size was 2.98 cm (range 1.5-5 cm). Mean breast volume was
458 cm3 (range 164-747 cm3). We calculated that if the
tumours were excised with a 0.5 cm margin, the excised tissue
would constitute on average 9% of the total breast volume.
This suggested that the patients included in the study would
have been suitable for conservative surgery.
A total of 667 blocks were prepared from the 30 breast
specimens. Nineteen breasts were found to harbour MCF. A
total of 54 MCF were detected. There were 21 foci of
hyperplasia without atypia, which were not included in the
analysis. Of the 54 MCF, 18 (33%) were detected by
radiography, and 28 (52%) were detected by gross inspection
and palpation and eight (15%) by both.
Of the 30 primary tumours, 27 were IDCs and three were
ILCs. Of the 54 MCF, four were ADH, 16 were DCIS, 17
were IDC, 11 were LCIS and six were ILC. There were no
foci showing ALH. Of 36 MCF with IDC as primary, 35
were ductal in origin and one was ILC. Of 18 MCF with ICL
as primary, 16 were lobular in origin and two were ADH.
The most malignant histological type of MCF in each breast
is given in Table I. The histological type of MCF (whether
infiltrating or in situ) was not related to its distance from the
edge of the primary tumour nor to the per cent volume of
breast tissue that would be required to be excised to include
the MCF.
We investigated whether MCF were generated by
lymphatic embolisation from the primary tumour. Lympha-
tic emboli were present within the primary tumour in 3 of the
27 primary IDCs. However, only one out of these three
breast specimens harboured an MCF, and this too was a
focus of DCIS. On the other hand, none of the nine
specimens that had IDC as MCF had lymphatic emboli in
the primary tumour, suggesting that MCF were not emboli
from the primary tumour but rather were independent
malignant foci. In addition, in our analysis of spatial
distribution in three dimensions as given below, we did not
find any evidence of communication between the primary
tumour and MCF.
Distance calculation
We found that 53% of patients had all MCF within 2 cm;
67% within 3 cm, 80% within 4 cm and 90% within 5 cm.
Thus, MCF would be left behind in 47% of patients if the
primary tumour were to be excised with a 2 cm margin, in
33% with a 3 cm margin, in 20% with a 4 cm margin and in
10% with a 5 cm margin. These findings are similar to those
observed by Holland et al. (1985) (Table II).
Relative distribution of MCF and primary tumour
On calculating the relative distribution of MCF and primary
tumour within the four quadrants of the breast, we found
that, whereas the primary tumour was most common in the
upper outer quadrant, MCF were widely distributed in all
four quadrants of the breast (Figure 1). The distribution of
the primary tumour and MCF in the four quadrants was
statistically significantly different (chi-square =8.65,
P=0.034) (Table III). When considered in terms of
conventional quadrants, out of the 19 cases that harboured
MCF, 14 had MCF outside the index quadrant (a 900 sector
of breast that had the primary tumour at its centre).
Volume calculation
We calculated the proportion ofpatients in whom MCF would
be left behind with increasing volume of breast tissue excised
Table I The most malignant histological type of MCF in infiltrating
duct and in infiltrating lobular carcinomas
The most malignant histological type of MCF
Primary tumour IDC ILC DCIS ILCS Nil
IDC (27) 9 1 6 11
ILC (3) - 2 -
IDC, infiltrating duct carcinoma; ILC, infiltrating lobular carcino-
ma; DCIS, ductal carcinoma in situ; ILCS, lobular carcinoma in situ;
MCF, multicentric focus.
Table II Per cent patients in whom MCF would be left behind with
increasing excision margin of primary tumour
Excision margin
ofprimary tumour Patients in whom MCF wouldbe left behind (%)
Holland et al. (1985) Present series
2 cm 42 47
3 cm 17 33
4 cm 10 20
5 cm - 10Muldcentricity of breast cancer: a whole-organ analysis
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Primary tumours Multicentric foci
Figure 1 Relative distribution of primary tumours and multicentric foci plotted in two dimensions.
with the tumour (expressed as per cent oftotal breast volume).
When all patients were considered, 18/30 (60%) had MCF
beyond 10% of the breast volume, 15/30 (50%) had MCF
beyond 25% of the breast volume (a quadrant), and 7/30
(23%) had MCF beyond 50% of total breast volume (Table
IV). However, when only those breasts that actually harboured
MCF were considered, then 95% of breasts (18/19) had MCF
beyond 10%, 79% ofbreasts (15/19) had MCF beyond 25% (a
quadrant) and 37% ofbreasts (8/19) had MCF beyond 50% of
breast volume including the tumour. Of the 15 cases that had
MCF beyond the index quadrant, seven were infiltrating, seven
were in situ and one was ADH. The discrepancy (14 vs 15)
between the results of two- and three-dimensional analysis is
related to the fact that in one case the MCF was within the
anatomical quadrant as conventionally defined in two
dimensions, but was beyond the 25% breast volume that
included the primary tumour.
We then calculated the distribution ofthe 54 MCF found in
the study within increasing volumes ofbreast tissue around the
tumour. Tables V and VI show these distributions for primary
IDC and primary ILC tumours respectively. They show that
the number ofMCF contained within 10%, 11 -25%, 26 -50%
and >50% of the breast volumes around the tumour were
similar, indicating that MCF are scattered throughout the
breast. The histological type of MCF (non-infiltrating or
infiltrating) also had similar distributions within increasing
volumes ofbreast tissue around the tumour. After exclusion of
ADH and LCIS these results remained unchanged.
In breast specimens that had IDC as primary tumour,
presence of multicentricity was related to tumour size. Four
out of 12 breast specimens with tumours <3 cm harboured
MCF, whereas 12 out of 15 breast specimens with tumours
, 3 cm harboured MCF (P=0.02). However, the actual
number of MCF present in each breast or their distance from
the edge of the primary tumour were not related to the
tumour size. The volume of breast, expressed as per cent of
the total breast volume, that would need to be excised to
remove all MCF, also did not correlate with the size of
primary tumour. There was no relationship between nodal
status, age or menopausal status of the patient and MCF
(their presence, actual number, distance from tumour edge or
the per cent volume of breast tissue that would be required to
be excised to include it with the excision of primary).
Discussion
We found that 63% of our patients harboured multicentric
foci in addition to the primary tumour. This incidence is
Table m Relative distribution ofprimary tumour and MCF in the
four breasts quadrants
Quadrant Primary tumour MCF
Upper outer 14 13
Upper inner 5 16
Lower outer 10 14
Lower inner 1 11
The distribution of primary tumour and MCF in the four breast
quadrants of the breast was significantly different. Chi-square=8.65,
P=0.034.
Table IV Per cent patients in whom MCF would be left behind
with increasing volume of breast tissue excised
Per cent oftotal breast Patients in whom MCF
volume excised would be left behind (%)
10 (-lumpectomy) 60
25 (-quadrantectomy) 50
50 23
Table V Number of MCF contained within increasing volumes of
breast tissue around the tumour, in 27 cases with primary IDC
MCF contained within that breast volume
Per cent volume Histological type of MCF
around the tumour Total no. ADH DCIS IDC ILC
<10 8 5 3 -
10-25 10 - 4 5 1
26-50 13 1 5 7 -
>50 5 1 2 2
ADH, ductal hyperplasia with atypia, for other abbreviations see
Table I.
Table VI Number of MCF contained within increasing volumes of
breast tissue around the tumour, in three cases with primary ILC
MCF contained within that breast volume
Per cent breast volume Histological type ofMCF
around the tumour Total no. ADH LCIS ILC
<10 6 5 1
11-25 2 - 1 1
26-50 6 1 5 -
>50 4 1 - 3
ADH, ductal hyperplasia with atypia, for other abbreviations see
Table I. Atypical lobular hyerplasia (ALH) was not detected in any of
the sections.Mc I 'map o 1 _ cmw a em-I.-a. X-iyds
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similar to that found by other workers using Egan's
technique [Lagios (1977) 56%, Egan (1982) 69% and
Holland et al. (1985) 63%J. Our findings regarding the
distribution of MCF around the primary tumour, expressed
as distances from the tumour edge, are similar to those of
Holland et al. (1985) (Table II). We found that 53% of
patients had MCF within 2 cm, 80% within 4 cm and 90%
within 5 cm of the tumour edge. The difference between our
study and that of Holland et al. (1985), however, lies in the
fact that the latter group did not take the size of the breast
into account, and expressed the distribution of MCF in only
one dimension. Expressed in one dimension, an impression is
created that MCF are mostly present around the primary
tumour. Our approach to the analysis in two- and three-
dimensions makes the following novel observations. (1) The
relative distribution of primary tumour and MCF in the four
breast quadrants was significantly different (P=0.034). We
found that the primary tumour was more common in the
upper outer quadrant whereas MCF were widely distributed
in all four quadrants, suggesting that MCF are widely
scattered throughout the breast. (2) When the 19 breasts that
actually harboured MCF were considered, in as many as
79% (15/19) MCF were present beyond 25% of breast
volume including the tumour (index quadrant). When all
patients were considered, half (15/30) harboured MCF
beyond the index quadrant. Thus, even if a quadrant were
excised, 50% of patients would still have MCF left behind.
The above findings are at variance with the suggestion
made by Holland et al. that MCF are present in the index
quadrant in 90% of cases. Is our sample size too small and
our findings a result ofchance? Let the hypothesis be, as has
been suggested by Holland et al. (1985), that in 90% of cases
MCF are contained within the index quadrant. If this
hypothesis were true, then 25% of breast volume including
the tumour would contain all MCF in 90% of breast
specimens. Thus we should have found all MCF within 25%
of breast volume in 27 of the 30 (90%) breast specimens. In
actual fact we found that all MCF were contained in the
index quadrant in only 15 of 30 (50%) breast specimens. The
probability of our finding being due to play ofchance is I in
1500 (27: 3 vs 15: 15, chi-square= 11.4, P=0.0007).
Our finding that MCF lie beyond the index quadrant in
50% of breast specimens may have implications for breast
conservation therapy (BCT). In large series of breast
conservation studies, it has been seen that >90% of early
breast recurrences occur in the quadrant that harboured the
primary tumour (Harris et al., 1981; Clark et al., 1982;
Schnitt et al., 1984; Clarke et al., 1985; Kurtz et al., 1989;
Boyages et al., 1990; Fowble et al., 1990; Fisher et al., 1992;
Clarke et al., 1992; Veronesi et al., 1993). This is true whether
or not radiotherapy is given (Fisher et al., 1992). If
recurrences were to arise from MCF, then we would expect
50% of recurrences to occur in other quadrants. As this is
not the case, we conclude that early recurrences do not arise
from MCF. Therefore, MCF in the index breast should
behave in a fashion similar to putative MCF present in the
opposite breast. This is borne out by the fact that recurrence
rate in the remaining quadrants of the index breast is
identical to that in the opposite breast (1% per year in both
cases, Kurtz et al., 1989). We believe that recurrences in the
index quadrant arise either from the orignal primary tumour
cells left behind or from circulating metastatic cancer cells
lodging in the higher vascular bed ofthe excised tumour. The
latter is supported by the fact that patients who have local
relapse in the breast after BCIT have a relatively poor
prognosis (Fisher et al., 1991; Van Dongen et al., 1992).
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